During the 2018 annual American Society of Hematology (ASH) meeting and when I was still a VP and Chief Medical Officer at Cardinal Health Specialty Solutions, I gave this interview to OBR on the potential risks faced by oncologists if they enter into a two-sided payment agreement with CMS. Reimbursement models continue to fascinate me and they are rather complex. I am not sure there is a perfect model out there, but let me know your thoughts.